by James on 4 September 2010
A study of genetic data from over 50,000 people has revealed a genetic link to migraine, and is providing new information about the source of migraine and its treatment. First of all, why are we even looking for genetic links? Well, for some time now we’ve had a reasonably good theory that migraine is genetically-based. [...]
by James on 30 March 2009
A couple of weeks ago I mysteriously referred to a drug called ADX10059, but didn’t say much about it. So let’s take a quick look at another new migraine drug that is currently in the testing phase. As I mentioned in the post The Latest on Tezampanel, a new Migraine Drug, ADX10059 also has to [...]
by James on 12 March 2009
Trials for the new migraine drug, Tezampanel (NGX424), are moving quickly ahead. So it’s time to catch up on what this drug is, and who it might help. Tezampanel is based on an emerging understanding of the role of glutamate (an amino acid) in pain. Targeting glutamate receptors (either through antagonists like Tezampanel or through [...]